Johnson & Johnson’s model fair value sits at US$252.87 per share, with analysts keeping price targets anchored to that ...

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has rallied 13.73% year to date and 55.27% over the past year, fueled by ...

Johnson & Johnson (JNJ) ended the recent trading session at $228.39, demonstrating a -2.48% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

The average retired worker receives about $24,000 a year from Social Security. Add a modest part-time job, the kind many retirees take for supplemental income rather than career advancement, and total ...

Johnson & Johnson (NYSE:JNJ) reported Phase 3 results for TALVEY plus DARZALEX FASPRO in relapsed or refractory multiple ...

Johnson & Johnson (NYSE:JNJ) is included among the Dividend Stock Portfolio: Top 10 Stocks to Buy According to Reddit. On May ...

Johnson & Johnson (JNJ) stock is in focus as CEO says the company won’t pursue GLP-1 obesity drugs and instead prioritize ...

Johnson & Johnson is scheduled to announce its earnings on Tuesday, April 15, 2025. Analysts expect earnings of $2.59 per share on revenue of $21.6 billion for the current year, compared to $2.71 per ...

Johnson & Johnson (JNJ) stock is in focus as trial data show the company's multiple myeloma drug Talvey's potential in an ...

Johnson & Johnson remains in focus as recent share strength meets valuation debate, defensive healthcare appeal, and MedTech ...

Johnson & Johnson (NYSE: JNJ) recently released its Q1 earnings, surpassing analyst estimates on both revenue and earnings. The company posted adjusted earnings of $2.77 per share on revenue of $21.9 ...